- Chembio Diagnostics Inc CEMI has received a $4 million purchase order from the Partnership for Supply Chain Management (PFSCM), supported by The Global Fund.
- The order comes to purchase Chembio's HIV 1/2 STAT-PAK Assay for shipment to Ethiopia into early 2022.
- The HIV 1/2 STAT-PAK Assay is a World Health Organization (WHO) prequalified, rapid point-of-care assay to detect HIV-1 and HIV-2 antibodies in fingerstick whole blood, venous whole blood, serum, or plasma.
- Recently, the Company received a $28.3 million purchase for its COVID-19 antigen tests for Brazil.
- Price Action: CEMI shares hit an upper circuit breaker twice are down 1.50% at $5.26 on profit booking during the market session on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
